EP2744809
4-(8-metoxý-1-((1-metoxýprópan-2-ýl)-2-(tetrahýdró-2h-pýran-4-ýl)-1H-imídasó[4,5-c]kínólín-7-ýl)-3,5-dímetýlísoxasól og notkun þess sem hemill brómsvæðis
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
15.8.2012EP published:
12.10.2016EP application number:
12748028.3
EP translation filed:
21.12.2016Grant published:
15.1.2017EPO information:
European Patent Register
Max expiry date:
14.8.2032Expiry date:
14.8.2019
Title:
4-(8-METHOXY-1-((1-METHOXYPROPAN-2-YL)-2-(TETRAHYDRO-2H-PYRAN-4-YL)-1 H-IMIDAZO[4,5-C]QUINOLIN-7-YL)-3,5-DIMETHYLISOXAZOLE AND ITS USE AS BROMODOMAIN INHIBITOR
Timeline
Today
15.8.2012EP application
12.10.2016EP Publication
21.12.2016Translation submitted
15.1.2017Registration published
14.8.2019Expires
Owner
Name:
GlaxoSmithKline LLCAddress:
Corporation Service Company 2711 Centerville Road Suite 400, 19808, Wilmington, DE, US
Inventor
Name:
DEMONT, Emmanuel, HubertAddress:
Stevenage Hertfordshire SG1 2NY, GB
Name:
JONES, Katherine, LouiseAddress:
Stevenage Hertfordshire SG1 2NY, GB
Name:
WATSON, Robert JAddress:
Stevenage Hertfordshire SG1 2NY, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201114103Date:
17.8.2011Country:
GB
Classification
Categories:
C07D 471/04, A61K 31/4745, A61P 29/00, A61P 37/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 14.7.2017
Expires: 14.8.2018
Payer: Örn Þór, slf.
Number: 7
Paid: 17.7.2018
Expires: 14.8.2019
Payer: Örn Þór, slf.